Phibro Animal Health Cash Flow Statement
NASDAQ: PAHCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Phibro Animal Health free cash flow
In fiscal 2026, Phibro Animal Health generated $69.0 million of operating cash flow and spent $59.1 million on capital expenditures. That left free cash flow of $9.9 million, a free-cash-flow margin of 0.6% of revenue. Free cash flow was down 76.4% from the prior year's $41.8 million.
Phibro Animal Health returned $19.5 million to shareholders through dividends, equal to 197% of free cash flow. Free cash flow covered dividend payments 0.5 times.
Summary generated from market data by MetaCap's automated system. Methodology
Phibro Animal Health cash flow statement (annual)
| Fiscal year (USD) | FY 20262026-06-30 | FY 20252025-06-30 | FY 20242024-06-30 | FY 20232023-06-30 | FY 20222022-06-30 | FY 20212021-06-30 | FY 20202020-06-30 | FY 20192019-06-30 | FY 20182018-06-30 | FY 20172017-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 99.72M | 48.26M | 2.42M | 32.61M | 49.17M | 54.38M | 33.55M | 54.71M | 64.88M | 64.61M |
| Net Income growth (YoY) | +106.61% | +1897.68% | -92.59% | -33.69% | -9.58% | +62.09% | -38.68% | -15.67% | +0.41% | -21.89% |
| Depreciation & Amortization | 51.51M | 45.60M | 36.18M | 34.01M | 32.70M | 31.89M | 32.34M | 27.56M | 26.94M | 26.00M |
| Stock-Based Compensation | 1.60M | 717.00K | 475.00K | — | — | 1.13M | 2.26M | 2.26M | 334.00K | 0 |
| Change in Working Capital | -123.04M | -70.29M | 17.00M | -36.14M | -46.07M | -29.16M | -3.03M | -39.74M | -33.61M | -3.46M |
| Operating Cash Flow | 68.95M | 80.12M | 87.59M | 13.31M | 31.65M | 48.31M | 59.35M | 47.17M | 70.01M | 98.39M |
| Capital Expenditures | -59.09M | -38.29M | -41.24M | -51.79M | -37.04M | -29.32M | -34.05M | -29.89M | -18.55M | -20.88M |
| Investing Cash Flow | -71.45M | -288.69M | -48.19M | -74.02M | -22.58M | -18.58M | -120.39M | -14.13M | -84.61M | -21.94M |
| Dividends Paid | -19.46M | -19.45M | -19.44M | -19.44M | -19.44M | -19.43M | -19.42M | -18.59M | -16.07M | -15.83M |
| Debt Issued | — | — | — | — | — | — | — | — | — | 250.00M |
| Debt Repaid | — | — | — | — | — | — | — | -12.65M | -6.40M | -285.53M |
| Financing Cash Flow | -6.56M | 207.13M | -6.77M | 26.99M | 16.34M | -17.00M | 40.94M | -4.11M | -11.78M | -53.74M |
| Net Change in Cash | -6.62M | -2.57M | 29.33M | -32.97M | 24.04M | 13.87M | -21.23M | 28.41M | -26.91M | 22.48M |
| Free Cash Flow | 9.87M | 41.83M | 46.36M | -38.48M | -5.39M | 18.99M | 25.30M | 17.28M | 51.46M | 77.50M |
This table shows 10 annual periods of Phibro Animal Health's cash flow statement, from FY 2026 back to FY 2017, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow PAHC's reporting calendar. What is a cash flow statement?